Advertisement
Home Tags Clinical Trials

Tag: Clinical Trials

Large clinical studies that are sponsored by industry are more likely to report favorable outcomes and less likely to report unfavorable outcomes than those sponsored by the National Institutes of Health

Cardiovascular Trial Sponsorship Significantly Impacts Findings

0
Favorable outcomes seven times more likely in industry- versus NIH-sponsored trials
Lower-income patients with cancer are less likely to participate in clinical trials

Lower-Income Cancer Patients Less Likely to Participate in Trials

0
Trial participation decreases with decreasing annual household income
Independent researchers couldn't reproduce the findings of more than half of 100 experiments previously published in three prominent psychology journals

Challenges in Replicating Results of Psychology Studies

0
Reason to suspect similar issues across disciplines, researcher says
In a position statement published online July 20 in the Journal of Clinical Oncology

ASCO Calls for Cancer Trials to Include More Seniors

0
Older adults react differently to treatment, oncology group notes
Among institutional review board members

Progress in Reporting Conflict of Interest Among IRB Members

0
Percentage of members who felt another member didn't disclose financial relationships down '05 to '14
Most fibromyalgia drug therapy randomized controlled trials are funded by industry

Majority of Fibromyalgia Drug Trials Are Industry Sponsored

0
Almost two-thirds of trials had one or more authors with financial conflicts of interest
Researchers are not promptly reporting the results of clinical trials to ClinicalTrials.gov

Clinical Trial Data Often Not Reported in Timely Manner

0
Delays in filing findings on new treatments mean patients aren't informed, researcher says
Disclosure of physician-industry relationships is important for potential participants in multiple sclerosis clinical trials and may impact participation in these trials

Patients Want Doctors to Disclose Ties to Industry in MS Trials

0
Potential participants in trials of MS therapies want to know about conflicts of interest